(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.48%) $83.45
(-1.16%) $1.619
(-0.05%) $2 346.00
(-0.30%) $27.17
(0.21%) $924.00
(-0.03%) $0.934
(-0.15%) $11.01
(-0.05%) $0.800
(0.00%) $92.17
Live Chart Being Loaded With Signals
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders...
Stats | |
---|---|
Dagens volum | 261 676 |
Gjennomsnittsvolum | 261 312 |
Markedsverdi | 66.40M |
EPS | $-0.290 ( 2024-04-02 ) |
Neste inntjeningsdato | ( $-0.280 ) 2024-05-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.230 |
ATR14 | $0.00500 (0.37%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-06 | Sandercock Colin | Buy | 175 000 | Stock Option (right to buy) |
2024-03-06 | Suri Anish | Buy | 300 000 | Stock Option (right to buy) |
2024-03-06 | Millar Kerri-ann | Buy | 250 000 | Stock Option (right to buy) |
2024-03-06 | Passeri Daniel R | Buy | 400 000 | Stock Option (right to buy) |
2024-03-06 | Levisetti Matteo | Buy | 260 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
97.99 |
Last 98 transactions |
Buy: 5 498 246 | Sell: 593 660 |
Volum Korrelasjon
Cue Biopharma Inc Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
NLTX | 0.886 |
RPHM | 0.872 |
RNAZ | 0.843 |
SGTX | 0.843 |
ACLX | 0.842 |
ADMP | 0.842 |
NISN | 0.834 |
SDIG | 0.833 |
RMRM | 0.832 |
VCXA | 0.828 |
10 Mest negative korrelasjoner | |
---|---|
TCBS | -0.877 |
CDW | -0.875 |
MYNZ | -0.87 |
RGP | -0.865 |
RBBN | -0.863 |
PTSI | -0.862 |
CASS | -0.858 |
HOFT | -0.858 |
LSAK | -0.846 |
FFBW | -0.844 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Cue Biopharma Inc Korrelasjon - Valuta/Råvare
Cue Biopharma Inc Økonomi
Annual | 2023 |
Omsetning: | $5.49M |
Bruttogevinst: | $2.05M (37.41 %) |
EPS: | $-1.110 |
FY | 2023 |
Omsetning: | $5.49M |
Bruttogevinst: | $2.05M (37.41 %) |
EPS: | $-1.110 |
FY | 2022 |
Omsetning: | $1.25M |
Bruttogevinst: | $-560 828 (-45.04 %) |
EPS: | $-1.480 |
FY | 2021 |
Omsetning: | $14.94M |
Bruttogevinst: | $14.94M (100.00 %) |
EPS: | $-1.410 |
Financial Reports:
No articles found.
Cue Biopharma Inc
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target and activate antigen-specific T cells for human papilloma virus-driven cancers. The company offers CUE-102, a fusion protein biologic to target and activate antigen-specific T cells to fight cancers; CUE-103 a CUE-100 series Immuno-STAT targeting the KRAS G12V mutation, including colorectal carcinoma, lung cancer, and pancreatic cancer; CUE-200 that focuses on cell surface receptors, including CD80 and/or 4-1BBL to address T cell exhaustion associated with chronic infections; and CUE-300 and CUE-400 framework to target various autoimmune diseases. Cue Biopharma, Inc. has collaboration agreements with Merck Sharp & Dohme Corp. for the research and development of its proprietary biologics that target various autoimmune disease indications; LG Chem Life Sciences for the development of Immuno-STATs focused on the field of oncology; and Albert Einstein College of Medicine. The company was formerly known as Imagen Biopharma, Inc. and changed its name to Cue Biopharma, Inc. in October 2016. Cue Biopharma, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.